Community Funding Opportunities

Health Services Research on Minority Health & Health Disparities (R21)

Due Date: 01-09-2017
The purpose of this FOA is to encourage innovative exploratory and developmental health services research to improve minority health and/or reduce health disparities at the health care system-level as well as within clinical settings. R01 also available

Discovery Funding Opportunities

Development of Appropriate Pediatric Formulations & Pediatric Drug Delivery Systems (R01)

Due Date: 05-05-2017
This FOA encourages grant applications to address different and complementary research needs for the development and acceptability of pediatric drug formulations in different age groups. Development and testing of novel pediatric drug delivery systems is also part of this initiative.

Detecting Cognitive Impairment, including Dementia, in Primary Care & Other Everyday Clinical Settings for the General Public & in Health Disparities Populations (UG3/UH3)

Due Date: 05-09-2017
The purpose of this FOA is to invite applications that address the unmet need to detect cognitive impairment, including dementia, in large and diverse populations seen in primary care across the United States, including in health disparities populations, when a patient, relative, or care provider indicates concern.

NIAID Clinical Trial Implementation Grant (R01)

Due Date: 05-12-2017
Encourages applications for implementation of investigator-initiated, hypothesis-driven, non-high-risk clinical trials that are considered a high priority by the National Institute of Allergy and Infectious Diseases (NIAID).

The Health & Retirement Study (U01)

Due Date: 05-16-2017
The purpose of this FOA is to solicit applications for the next six-year cycle of the study, which is the leading longitudinal data resource on patterns of age-related changes in the health and well-being of adults age 50 and older in the U.S.

2017 BRCA 1,2 Research Collaborative Grants

Due Date: 05-19-2017
The Convergence Team Award supports research projects that leverage novel collaborations between biomedical scientists and other researchers that might be brought into the field to work together across disciplines to drive our understanding and treatment of BRCA 1,2 related cancers. The research may be basic, translational, clinical, or epidemiological in nature. Collaborations within and between research institutions is encouraged. Translational Award projects should move a novel strategy from the laboratory into a human clinical trial or use specimens from a clinical trial to develop biomarkers or mechanisms.

NINDS Program Project Grant (P01)

Due Date: 05-25-2017
The National Institute of Neurological Disorders and Stroke's (NINDS) program project grants support investigator-initiated research programs, consisting of three or more highly interdependent projects, in which a team of investigators works in a clearly defined area of mutual scientific interest.

NIH/NCI: Early Phase Clinical Trials in Imaging & Image-Guided Interventions (R01)

Due Date: 05-28-2017
This FOA supports clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided planning, and/or execution therapy, contrast kinetic modeling, 3-D reconstruction, and other quantitative tools.

Shared Instrumentation Grant (SIG) Program (S10)

Due Date: 05-31-2017
The program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $50,000.

High-End Instrumentation (HEI) Grant Program (S10)

Due Date: 05-31-2017
The program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems that cost at least $600,001.

Center of Excellence for Research on Complementary & Integrative Health (P01)

This FOA encourages the submission of applications that requires multi-project, synergistic collaboration between outstanding scientists that blends multiple research approaches by multi-disciplinary research teams.

Charles Koch Foundation Grant Proposal

The foundation supports research that spurs social progress, well-being, and long-term prosperity. Open requests are available for a select number of issues.

PCORI: Engagement Award Initiative Notice: Patient-Centered Outcomes Research/Clinical Comparative Effectiveness Research Meeting & Conference Support

Due Date: 06-01-2017
This award includes guidelines for available funding support for meetings and conferences that align with PCORI¿s mission and strategic plan and facilitate expansion of patient-centered outcomes research/clinical comparative effectiveness research.

NIH Health Care Systems Research Collaboratory: Demonstration Projects for Pragmatic Clinical Trials

Due Date: 06-02-2017
Trials must be conducted across two or more health care systems and must be conducted as part of the NIH HCS Research Collaboratory supported through the NIH Common Fund. Any ACTSI investigators interested in applying should contact Lance Waller to discuss biostatistical support.

Administrative Supplements to CTSA Program Hubs to Develop Best Practices for sIRB Implementation

Due Date: 06-02-2017
The Clinical and Translational Science Awards (CTSA) Program involves multi-site clinical research and may not be currently using a single Institutional Review Board (sIRB). FY2017 funds have been allocated to support approximately 10-11 administrative supplements (~300K/award) for infrastructure development at CTSA Program hub institutions expected to follow the "NIH Policy on the Use of a Single Institutional Review Board for Multi-Site Research.¿ NCATS is therefore soliciting requests from CTSA Program hub institutions with current NIH-funded award(s) for one year of supplemental support to cover direct costs for the development of costing models, business processes, system changes, and efficient procedures and tools needed to facilitate sIRB review for multi-site research.

Research in Congenital Heart Disease

Due Date: 06-02-2017
The Children's Heart Foundation has issued a call for research proposals focused on clinical pediatric cardiology, basic science, and the advancement of surgical techniques. Grants will be awarded for new research in the areas of molecular genetics/biochemistry, devices/procedural research (catheterization and surgical), and long-term care of children with congenital heart defects as they become adults.

Chronic Condition Self-Management in Children & Adolescents (R01)

Due Date: 06-05-2017
To encourage research to improve self-management and quality of life in children and adolescents with chronic conditions, including research that takes into consideration various factors that influence self-management such as individual differences, biological and psychological factors, family and sociocultural context, family-community dynamics, healthcare system factors, technological advances, and the role of the environment.

Reducing Health Disparities Among Minority & Underserved Children (R01)

Due Date: 06-05-2017
This initiative is designed to stimulate research that targets the reduction of health disparities among children. For purposes of this FOA, "health disparities" applies to children who have limited access to resources and privileges that impact their health.

Foundation for Women¿s Wellness: Research Awards

Due Date: 06-20-2017
The awards target early funding for small, short-term studies with promise for improving medical knowledge in cardiovascular disease, leading female cancers, the role of hormones in disease and stage-of-life health issues such as pregnancy and menopause and diseases disproportionately affecting women

Transformative High Resolution Cryoelectron Microscopy Program: Support for the Creation of National Centers of Cryoelectron Microscopy

Due Date: 06-30-2017
The NIH Common Fund program in Transformative High Resolution Cryoelectron Microscopy (cryoEM) aims to accelerate and broaden the impact of recent dramatic advances in cryoEM technology on the biomedical research community. The centers will provide access to state-of-the-art equipment, technical support, and cross-training for the production and analysis of high-resolution data.

Pipeline to Proposal Awards Tier A Pre-Engagement/Community Projects

Due Date: 06-30-2017
The purpose of the program is to help people form new collaborations with the goal of developing proposals for research with sound scientific rigor and robust patient engagement. PCORI is interested in research teams that include patients, caregivers, clinicians, and other healthcare stakeholders, as well as researchers.

American Diabetes Association Pathway Grants

Due Date: 07-03-2017
Pathway to Stop Diabetes is a bold, innovative initiative designed to radically transform diabetes research. Our Vision is simple yet revolutionary: find a new generation of brilliant scientists at the peak of their creativity, and provide them with freedom, autonomy, and the financial and professional resources to set them on the road to breakthrough discoveries.

Establishment of Research Centers to Investigate the FVIII Immune Response in Patients with Hemophilia A (U54)

Due Date: 07-07-2017
The goal of this FOA is to establish up to four Centers to utilize cross-disciplinary science and novel technologies to define the basic mechanisms involved in the development of anti-FVIII neutralizing antibodies, also known as FVIII inhibitors, in patients with congenital hemophilia A.

Integrative Computational Biology for Analysis of NHLBI TOPMed Data

Due Date: 07-06-2017
The purpose of this FOA is to support integrated analysis of whole genome, large scale ¿omic¿ data generated by the NHLBI¿s Trans-Omics for Precision Medicine (TOPMed) program and associated phenotype and clinical data using systems approaches. Ultimately, these studies will advance our understanding of the molecular underpinnings of heart, lung, blood, and sleep disease.

Translational Research in Pediatric & Obstetric Pharmacology & Therapeutics (R01)

Due Date: 07-07-2017
The purpose of this FOA is to encourage applications for translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and in women during pregnancy and lactation.

National Institute on Aging: Resource Centers for Minority Aging Research (P30)

Due Date: 07-20-2017
The primary purpose of this FOA is to support centers that will enhance the diversity of the aging research workforce by mentoring promising scientists from under-represented groups for sustained careers in aging research in a selected area of scientific focus, and to develop infrastructure to promote advances in this area and increase the number of researchers focused on the health and well-being of minority elders.

NIDA Translational Avant-Garde Award for Development of Medication to Treat Substance Use Disorders (UG3/UH3)

Due Date: 07-25-2017
The purpose of this award is to support outstanding basic and/or clinical researchers with the vision and expertise to translate research discoveries into medications for the treatment of Substance Use Disorders (SUDs) stemming from tobacco, cannabis, cocaine, methamphetamine, heroin, or prescription opiate use. Eligible applicants must demonstrate the ability to develop molecules with the potential to treat SUDs and advance them in the drug development continuum. The ultimate goal of this FOA is to bring molecules closer to FDA approval.

NIDCD Research Grants for Translating Basic Research into Clinical Tools (R01) PAR-17-184

Due Date: 09-18-2017
This funding opportunity seeks teams comprising basic and clinical researchers and clinicians to develop tools for improved diagnosis, treatment, and prevention of hearing, balance, smell, taste, voice, speech, or language disorders.

NIDDK: George M. O'Brien Kidney Research Core Centers (P30)

Due Date: 10-01-2017
The goal of the O'Brien Kidney Research Center program is to make state-of-the art technologies and resources readily accessible to a broad spectrum of investigators pursuing studies in relevant topic areas.

Pragmatic Research in Healthcare Settings to improve Kidney Disease Prevention & Care (R18)

Due Date: 10-24-2017
The purpose of this FOA is to encourage research applications to test approaches to improve kidney disease prevention and/or treatment in routine healthcare settings. Research applications should be designed to test practical and potentially sustainable strategies that target the prevention or improved care of kidney disease, or the prevention or delay of the complications of kidney disease. The goal of the research is to obtain results that will improve routine healthcare practice and inform healthcare policy for the prevention or management of these conditions.

Biomarkers: Bridging Pediatric & Adult Therapeutics (R21)

This FOA encourages grant applications that propose adapting adult biomarkers to children. This would include the application and validation of biomarkers developed in adults to pediatric diagnosis, prognosis, and estimation of disease progression, toxicity, and response to therapy.

Advancing the Science of Geriatric Palliative Care (R01 & R21)

This FOA encourages exploratory or developmental research grant applications to develop new tools, methods, and models focused on palliative care in geriatric populations. The request for applications covers studies in a variety of healthcare or community settings. R01 and R21 available

RJWF Evidence for Action: Investigator-Initiated Research to Build a Culture of Health

Evidence for Action (E4A), a national program of the Robert Wood Johnson Foundation, funds research that expands the evidence base needed to build a Culture of Health. Their mission is to support rigorously designed quantitative, qualitative, and mixed methods research that yields convincing findings regarding the population health, well-being, and equity impacts of specific policies, programs and partnerships.

NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02 and UG3/UH3)

The program is designed to develop partnerships between pharmaceutical companies and the biomedical research community to advance therapeutics development. X02, UG3/UH3, and pediatric UG3/UH3 available.

Quick Wins

Are you frustrated with a device that you use? Is there a clinical process you see that needs improvement? Do you have a brilliant idea for a system, device, or program that would make life better `For the Kids¿? Quick Wins is a funding program put in place to provide rapid solutions to unmet clinical and business needs at Children¿s Healthcare of Atlanta.

Training Funding Opportunities

AHRQ: Mentored Clinical Scientist Research Career Development Award (K08)

The overall goal of AHRQ-supported career development programs is to help ensure that a diverse pool of highly trained health services researchers are available in adequate numbers and in appropriate research areas to address the mission and priorities of AHRQ.

NCATS & Eli Lilly Externship Opportunity

Due Date: 05-01-2017
This is an opportunity for an externship in clinical and translational sciences at Eli Lilly and Company for scholars, trainees, and investigators who are supported by the National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Award (CTSA) Program. The externship will support the training and education of participants in techniques and principles needed for translational research.

Research Initiative for Scientific Enhancement (RISE) (R25)

Due Date: 05-25-2017
The over-arching goal of this NIGMS R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral, and clinical research workforce.

CFAR Adelante Program

Due Date: 05-25-2017
Through the Center for AIDS Research (CFAR) Adelante Program, the CFARs strive to mentor and develop early-career investigators who focus on HIV/AIDS treatment, prevention, and care in the Latino/Hispanic community. A long-term goal of the program is to decrease HIV-related health disparities in the Hispanic/Latino community.

Neurosurgeon Research Career Development Program (NRCDP) (K12)

Due Date: 05-30-2017
The purpose of this FOA is to invite applications to continue support of a national program of mentored research career development for junior neurosurgeon faculty at institutions nationwide that support neurosurgical research. The goal of the program is to expand the cadre of neurosurgeon investigators trained to conduct research into neurological disorders, making use of their neurosurgical training.

NIMH Bio-behavioral Research Awards for Innovative New Scientists (NIMH BRAINS) (R01)

Due Date: 06-20-2017
The award is intended to support the research and research career advancement of outstanding, exceptionally productive scientists who are in the early, formative stages of their careers and who plan to make a long term career commitment to research in specific mission areas of the NIMH. This award seeks to assist these individuals in launching an innovative clinical, translational, basic or services research program that holds the potential to profoundly transform the understanding, diagnosis, treatment, or prevention of mental disorders.

Crohn's & Colitis Foundation of America Awards

Due Date: 07-01-2017
Research Fellowship Awards are intended to support individuals in the postdoctoral phase of their career to develop skills related to basic and/or clinical investigation in the field of inflammatory bowel disease (IBD), or Crohn¿s disease and ulcerative colitis. Career Development Awards are mentored awards intended to facilitate the development of individuals with research potential to prepare for a career of independent basic and/or clinical investigation in the area of IBD.

GILEAD Research Scholars Programs

Due Date: 07-07-2017
The Cardiovascular Disease Program supports innovative scientific research that will advance knowledge in the field of cardiovascular disease. The Cystic Fibrosis Program supports innovative scientific research that will advance knowledge in the fields of pediatric and adult cystic fibrosis and provide support for early research career development. The Pulmonary Arterial Hypertension Program supports innovative scientific research that will advance knowledge in the field of pulmonary arterial hypertension.

Lasker/NIH Clinical Research Scholars

Due Date: 08-25-2017
This is a competitive opportunity for early-stage physician-scientists to conduct independent clinical and translational research as tenure-track investigators at the NIH and in academia. It was established to create career research opportunities for physician-scientists (it also includes dental and nurse scientists) and is targeted to outstanding post-fellowship physicians and other clinicians with strong research interests and credentials.

NIH National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (R25)

Due Date: 09-25-2017
The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIGMS R25 program is to support educational activities that enhance the diversity of the biomedical research workforce. To accomplish this goal, the FOA will support creative educational activities with a primary focus on Courses for Skills Development and Research Experiences.

Commercialization Funding Opportunities

Mass General Hospital Student Prize Award: Technology Innovations Directed at the Needs of Primary Care in Medicine

Due Date: 05-01-2017
This competition, to encourage engineering-student interest in the challenges of primary care, is administered by the ¿Ambulatory Care of the Future¿ program of the Massachusetts General Hospital. Any graduate or undergraduate student in any U.S. university engineering or science department may enter. Note that early planning greatly increases a student¿s chances of success. Forming teams and collaborations is important.

SBIR Phase II Bridge Awards to Accelerate the Development of Cancer Therapeutics, Imaging Technologies, Interventional Devices, Diagnostics, & Prognostics toward Commercialization (R44)

Due Date: 07-06-2017
This FOA solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for projects that were previously funded under SBIR or STTR Phase II awards from any federal agency. Projects proposed in response to this FOA must be applicable to one of the following areas: (1) cancer therapeutics; (2) cancer imaging technologies, interventional devices, and/or in vivo diagnostics; or (3) in vitro and ex vivo cancer diagnostics and prognostics.

Small Business Innovation Research on Rare Musculoskeletal, Rheumatic, & Skin Diseases (SBIR) (R43)

Due Date: 07-10-2017
This FOA solicits Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose preclinical studies to advance the development of biomarkers or treatments for rare musculoskeletal, rheumatic. or skin diseases. Also eligible for potential funding through this initiative are studies of FDA-designated orphan products for musculoskeletal, rheumatic, or skin diseases.

Upcoming Events

View All Events

Funding News


Catching Up with Capstone

The Biomedical Engineering (BME) Capstone Design course at Georgia Institute of Technology is an opportunity for students from diverse realms of engineering to design, build, and test prototypes with real world applications. This culminates into...


Going Incognito: ACTSI Investigator Improves Transfusion Methods through Complement Transformation

Sean Stowell, MD, PhD, member of the Center for Transfusion and Cellular Therapies and assistant professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, is supported by ACTSI’s Pilot Grants...